ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 65 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $5,000 | -58.3% | 8,091 | -16.4% | 0.00% | – |
Q3 2018 | $12,000 | -92.3% | 9,684 | -91.6% | 0.00% | – |
Q2 2018 | $156,000 | +39.3% | 115,856 | +49.7% | 0.00% | – |
Q1 2018 | $112,000 | -35.3% | 77,367 | +0.5% | 0.00% | – |
Q4 2017 | $173,000 | +8.1% | 76,950 | +63.1% | 0.00% | – |
Q3 2017 | $160,000 | +15.1% | 47,182 | +20.3% | 0.00% | – |
Q2 2017 | $139,000 | -50.7% | 39,219 | -52.8% | 0.00% | – |
Q1 2017 | $282,000 | -59.1% | 83,124 | -44.6% | 0.00% | – |
Q4 2016 | $690,000 | +1201.9% | 150,130 | +1099.7% | 0.00% | – |
Q3 2016 | $53,000 | +211.8% | 12,514 | +71.8% | 0.00% | – |
Q2 2016 | $17,000 | -50.0% | 7,284 | -2.3% | 0.00% | – |
Q1 2016 | $34,000 | +13.3% | 7,459 | -1.9% | 0.00% | – |
Q4 2015 | $30,000 | +3.4% | 7,604 | -1.1% | 0.00% | – |
Q3 2015 | $29,000 | -6.5% | 7,692 | +10.6% | 0.00% | – |
Q2 2015 | $31,000 | +14.8% | 6,952 | +76.1% | 0.00% | – |
Q1 2015 | $27,000 | +800.0% | 3,948 | +311.2% | 0.00% | – |
Q4 2014 | $3,000 | – | 960 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 3,699,848 | $15,687,000 | 2.68% |
Northeast Financial Consultants Inc | 732,265 | $3,105,000 | 1.31% |
WEDBUSH SECURITIES INC | 15,000 | $64,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $628,000 | 0.01% |
THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,752,000 | 0.01% |
Virtu KCG Holdings LLC | 72,989 | $309,000 | 0.01% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,555 | $151,000 | 0.00% |
WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $64,000 | 0.00% |
BlackRock Fund Advisors | 612,231 | $2,596,000 | 0.00% |
Spot Trading L.L.C | 15,000 | $64,000 | 0.00% |